Angiodynamics ANGO
NASDAQ ANGO
$12.42 +0.35 (+2.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Angiodynamics (ANGO) EV to EBITDA (2009 - 2023)

Updated

Angiodynamics' (ANGO) EV to EBITDA stood at 9.65 in fiscal Q2 2024 (quarter ended Nov 30, 2023), down 1.6% from the prior quarter.

Analysis

Angiodynamics (ANGO) EV to EBITDA (2009 - 2023) Analysis & Trends

On a TTM basis, Angiodynamics' EV to EBITDA came in at 3.32 as of Nov 30, 2023; for FY2022 (ended May 31, 2022), it was 842.94.

  • Across earlier fiscal years, EV to EBITDA came in at 29.07 in FY2019 (-63.0%) and 78.66 in FY2018 (+111.7%).
  • The fiscal Q2 2024 figure is the lowest quarterly EV to EBITDA since fiscal Q3 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Angiodynamics 20.48 Mn -146.80 Mn 48.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2023 -2.41
Aug 31, 2023 -1.65
May 31, 2022 2.20
Feb 29, 2020 -0.58
Nov 30, 2019 -0.91
Aug 31, 2019 -2.61
May 31, 2019 -12.10
Aug 31, 2018 2.97
May 31, 2018 -4.90
Aug 31, 2017 -2.46
May 31, 2017 -1.95
Feb 28, 2017 -0.27
Nov 30, 2016 -0.29
Aug 31, 2016 -0.41
May 31, 2016 -0.57
Feb 29, 2016 -0.24
Nov 30, 2015 -0.16
Aug 31, 2015 -0.03
May 31, 2015 0.10
Feb 28, 2015 0.19
API Access

Angiodynamics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ANGO&period=max&api_key=YOUR_API_KEY